Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s disease

Alzheimer´s disease (AD) is a neurodegenerative disorder characterized by abnormal accumulation of β-amyloid and tau and synapse dysfunction in memory-related neural circuits. Pathological and functional changes in the medial temporal lobe, a region essential for explicit memory encoding, contribute...

Full description

Bibliographic Details
Main Authors: Carlos A Saura, Arnaldo eParra-Damas, Lilian eEnríquez-Barreto
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-08-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00318/full
_version_ 1818898251974180864
author Carlos A Saura
Arnaldo eParra-Damas
Lilian eEnríquez-Barreto
author_facet Carlos A Saura
Arnaldo eParra-Damas
Lilian eEnríquez-Barreto
author_sort Carlos A Saura
collection DOAJ
description Alzheimer´s disease (AD) is a neurodegenerative disorder characterized by abnormal accumulation of β-amyloid and tau and synapse dysfunction in memory-related neural circuits. Pathological and functional changes in the medial temporal lobe, a region essential for explicit memory encoding, contribute to cognitive decline in AD. Surprisingly, functional imaging studies show increased activity of the hippocampus and associated cortical regions during memory tasks in presymptomatic and early AD stages, whereas brain activity declines as the disease progresses. These findings suggest an emerging scenario where early pathogenic events increase neuronal excitability leading to enhanced brain activity before clinical manifestations of the disease, a stage that is followed by decreased brain activity as neurodegeneration progresses. The mechanisms linking pathology with synaptic excitability and plasticity changes leading to memory loss in AD remain largely unclear. Recent studies suggest that increased brain activity parallels enhanced expression of genes involved in synaptic transmission and plasticity in preclinical stages, whereas expression of synaptic and activity-dependent genes are reduced by the onset of pathological and cognitive symptoms. Here, we review recent evidences indicating a relationship between transcriptional deregulation of synaptic genes and neuronal activity and memory loss in AD and mouse models. These findings provide the basis for potential clinical applications of memory-related transcriptional programs and their regulatory mechanisms as novel biomarkers and therapeutic targets to restore brain function in AD and other cognitive disorders.
first_indexed 2024-12-19T19:29:07Z
format Article
id doaj.art-7782fb5a192b4997aece7d14028e730f
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-12-19T19:29:07Z
publishDate 2015-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-7782fb5a192b4997aece7d14028e730f2022-12-21T20:08:41ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022015-08-01910.3389/fncel.2015.00318152848Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s diseaseCarlos A Saura0Arnaldo eParra-Damas1Lilian eEnríquez-Barreto2Universitat Autónoma de BarcelonaUniversitat Autónoma de BarcelonaUniversitat Autónoma de BarcelonaAlzheimer´s disease (AD) is a neurodegenerative disorder characterized by abnormal accumulation of β-amyloid and tau and synapse dysfunction in memory-related neural circuits. Pathological and functional changes in the medial temporal lobe, a region essential for explicit memory encoding, contribute to cognitive decline in AD. Surprisingly, functional imaging studies show increased activity of the hippocampus and associated cortical regions during memory tasks in presymptomatic and early AD stages, whereas brain activity declines as the disease progresses. These findings suggest an emerging scenario where early pathogenic events increase neuronal excitability leading to enhanced brain activity before clinical manifestations of the disease, a stage that is followed by decreased brain activity as neurodegeneration progresses. The mechanisms linking pathology with synaptic excitability and plasticity changes leading to memory loss in AD remain largely unclear. Recent studies suggest that increased brain activity parallels enhanced expression of genes involved in synaptic transmission and plasticity in preclinical stages, whereas expression of synaptic and activity-dependent genes are reduced by the onset of pathological and cognitive symptoms. Here, we review recent evidences indicating a relationship between transcriptional deregulation of synaptic genes and neuronal activity and memory loss in AD and mouse models. These findings provide the basis for potential clinical applications of memory-related transcriptional programs and their regulatory mechanisms as novel biomarkers and therapeutic targets to restore brain function in AD and other cognitive disorders.http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00318/fullAmyloidGene Expression RegulationMemory DisordersTranscriptomeAlzheimer's diseaseCREB
spellingShingle Carlos A Saura
Arnaldo eParra-Damas
Lilian eEnríquez-Barreto
Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s disease
Frontiers in Cellular Neuroscience
Amyloid
Gene Expression Regulation
Memory Disorders
Transcriptome
Alzheimer's disease
CREB
title Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s disease
title_full Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s disease
title_fullStr Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s disease
title_full_unstemmed Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s disease
title_short Gene expression parallels synaptic excitability and plasticity changes in Alzheimer´s disease
title_sort gene expression parallels synaptic excitability and plasticity changes in alzheimer 180 s disease
topic Amyloid
Gene Expression Regulation
Memory Disorders
Transcriptome
Alzheimer's disease
CREB
url http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00318/full
work_keys_str_mv AT carlosasaura geneexpressionparallelssynapticexcitabilityandplasticitychangesinalzheimer180sdisease
AT arnaldoeparradamas geneexpressionparallelssynapticexcitabilityandplasticitychangesinalzheimer180sdisease
AT lilianeenriquezbarreto geneexpressionparallelssynapticexcitabilityandplasticitychangesinalzheimer180sdisease